This compound is a hydroxylated metabolite of agomelatine, formed through oxidative metabolism. It is primarily used as a reference standard in pharmaceutical research and quality control applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 152302-45-9
7-Desmethyl-3-hydroxyagomelatine
pharmaceutical intermediate
Imatinib
pharmaceutical raw material
Oxytetracycline hemicalcium salt
pharmaceutical raw material
(S,R,R,R)-nebivolol hydrochloride
pharmaceutical raw material
Trans-tramadol
pharmaceutical raw material
N-[2-(7-hydroxynaphthalen-1-yl)ethyl]acetamide
UNTZQBYXDYYXIY-UHFFFAOYSA-N
CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)O